Literature DB >> 3593349

Effect of extracellular calcium on vascular contraction induced by phorbol ester.

M Sawamura, Y Kobayashi, Y Nara, K Hattori, Y Yamori.   

Abstract

In rat thoracic aorta, 12-0-tetradecanoyl-phorbol-13-acetate (TPA) caused a slowly onset, sustained vascular contraction. The contraction was markedly reduced in the absence of extracellular Ca2+, although small tension development was still observed. The tension developed by TPA in the presence of Ca2+ was decreased by serial addition of a Ca2+-channel blocker, verapamil in a concentration-dependent manner. TPA could cause vascular contraction to almost maximum level at lower concentration of extracellular Ca2+, compared with KCl- or norepinephrine-induced contraction. These results suggest that extracellular Ca2+ which influxes through Ca2+-channels into cytoplasm is necessary for full tension development by TPA, and that TPA increases sensitivity of contractile mechanisms coupling with Ca2+.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593349     DOI: 10.1016/0006-291x(87)91348-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Protein kinase C-mediated contractile responses of arteries from diabetic rats.

Authors:  W Abebe; K M MacLeod
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

2.  Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries.

Authors:  J P Savineau; R Marthan; H Crevel
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

3.  Existence of two components in the tonic contraction of rat aorta mediated by alpha 1-adrenoceptor activation.

Authors:  K Nishimura; M Ota; K Ito
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Phorbol ester cardiotoxicity: are .O2-radicals involved?

Authors:  E Esser; G Loschen; L Flohé
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.